Applied Therapeutics Inc expected to post a loss of 26 cents a share - Earnings Preview

Applied Therapeutics

03/11/2023 17:30

* Applied Therapeutics Inc  APLT.OQ   APLT.O  is expected
to show
no change in quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for Applied
Therapeutics Inc
is for a loss of 26 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Applied
Therapeutics Inc is $5​, above​ its last closing price of $2.31.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.17       -0.26      -0.37     Missed  -39.6
 Mar. 31 2023  -0.27       -0.31      -0.18     Beat    41.3
 Dec. 31 2022  -0.41       -0.46      -0.16     Beat    65.4​
 Sep. 30 2022  -0.48       -0.48      -0.40     Beat    16.2
 ​​Jun.        -0.82       -0.78      -0.80     Missed  -1.9
 30 2022                                                
 Mar. 31 2022  -0.85       -0.83      -0.88     Missed  -5.6​
 Dec. 31 2021  -1.26       -1.25      -1.04     Beat    16.6
 Sep. 30 2021  -1.15       -1.16      -1.09     Beat    6.3
 This summary was machine generated November 3 at 17:30 GMT.  All
figures in US dollars  unless otherwise stated